PTCT

NASDAQ HEALTHCARE

PTC Therapeutics Inc

$62.67

$0.39 (+0.63%)

Live quote

52w: $58.90 – $90.87

Loading chart…

P/E Ratio7.62

P/B Ratio—

EV/EBITDA—

Debt/Equity—

ROE—

ROIC—

Revenue Growth114.51%

Gross Margin—

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for patients with rare disorders. The company is headquartered in South Plainfield, New Jersey.

Own PTCT? Track it here.

Create a free account to add PTCT to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account